Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer


Ozgur E. , Ferhatoglu F., Sen F. , Saip P., Gezer U.

CANCER BIOMARKERS, cilt.27, ss.11-17, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 27 Konu: 1
  • Basım Tarihi: 2020
  • Doi Numarası: 10.3233/cbm-190085
  • Dergi Adı: CANCER BIOMARKERS
  • Sayfa Sayısı: ss.11-17

Özet

BACKGROUND: Novel biomarkers are needed to predict the effectiveness of the treatment of presurgical neoadjuvant chemotherapy (NAC) in breast cancer (BC).